Apple Inc. vs. REGENERX BIOPHARMS INC
Apple Inc. and REGENERX BIOPHARMS INC are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| AAPL | RGRX | |
|---|---|---|
| Market Cap | $4.87 trillion | — |
| Revenue (TTM) | $466.82 billion | — |
| Net Income (TTM) | $128.93 billion | — |
AAPL and RGRX split the size & scale factors evenly.
Valuation
| AAPL | RGRX | |
|---|---|---|
| P/E Ratio | 38.31 | — |
| Price / Book | 45.29 | — |
| Price / Sales | 10.43 | — |
AAPL and RGRX split the valuation factors evenly.
Profitability
| AAPL | RGRX | |
|---|---|---|
| Net Margin | 27.62% | — |
| Return on Equity | 119.91% | — |
AAPL and RGRX split the profitability factors evenly.
Dividend
| AAPL | RGRX | |
|---|---|---|
| Dividend Yield | 0.32% | — |
| Payout Ratio | 12.40 | — |
AAPL and RGRX split the dividend factors evenly.
Risk & Sentiment
| AAPL | RGRX | |
|---|---|---|
| Short Interest | 0.31% | — |
AAPL and RGRX split the risk & sentiment factors evenly.
Dig deeper: AAPL overview, AAPL financials, RGRX overview, RGRX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.